Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

BACKGROUND: From March to April 2020, Spain was the center of the SARS-CoV-2 pandemic, particularly Madrid with approximately 30% of the cases in Spain. The aim of this study is to report the suspected serious adverse drug reactions (SADRs) in COVID-19 patients vs. non-COVID-19 patients detected by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez, Elena, Urroz, Mikel, Rodríguez, Amelia, González-Muñoz, Miguel, Martín-Vega, Alberto, Villán, Yuri, Seco, Enrique, Monserrat, Jaime, Frías, Jesús, Carcas, Antonio J., Borobia, Alberto M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744878/
https://www.ncbi.nlm.nih.gov/pubmed/33343374
http://dx.doi.org/10.3389/fphar.2020.602841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744878/
https://www.ncbi.nlm.nih.gov/pubmed/33343374
http://dx.doi.org/10.3389/fphar.2020.602841

Ejemplares similares